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Abstract Primary astrocyte cultures prepared from neonatal
hippocampus, cerebral cortex and cerebellum were morphologi-
cally distinct. Cells from hippocampus and cortex were almost
entirely protoplasmic, whereas cerebellar astrocytes had many
processes; in the absence of serum these differences were
accentuated. We compared the immunocontent and secretion of
the mitogenic protein S100B in these cultures. Immunocontent
was 2.5 times higher in cerebellar astrocytes than in hippocampal
or cortical astrocytes. Cells from all three regions secreted
S100B under basal conditions, but the secretion rate was higher
in cerebellar astrocytes. Secretion depended on protein synthesis
and was increased by incubation with forskolin or lysophos-
phatidic acid in mechanisms which were additive. The stellate
morphology induced by forskolin was reversed by lysophos-
phatidic acid in hippocampal but not in cerebellar cultures,
suggesting that S100B secretion was not associated with a
process-bearing phenotype of astrocytes. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
It is now generally recognized that astrocytes are heteroge-
neous in morphology and biochemistry with diverse functions
and complex interactions with neurons [1^5]. Astrocytes syn-
thesize various growth factors, cytokines and components of
the extracellular matrix, some of which have been shown to
rescue damaged neurons in model lesions of the CNS [6^8].
Biochemically distinct astrocytes have been demonstrated in
primary cultures of astrocytes [9] and such astroglial hetero-
geneity in situ may re£ect regional specializations in local
neurons. Moreover astrocytes from di¡erent brain regions
and at di¡erent developmental stages are heterogeneous in
multiple features including receptors and ion channels [10,11].
The protein S100B belongs to the S100 family of calcium
binding proteins and is considered a marker of astrocytes [12].
The protein is secreted by astrocytes and plays a neurotrophic
role in neighboring cells, as well as possessing autocrine func-
tions regulating astrocytic proliferation [13]. Further many
studies have suggested an intracellular role for S100B partic-
ularly in the regulation of the cytoskeleton. Considering the
importance of the cytoskeleton in regulating cell morphology
it appeared possible that variation in the synthesis, content
and secretion of S100B might be associated with morpholog-
ical variation. To investigate this possibility we have studied
astrocyte morphology and the immunocontent and secretion
of S100B in primary cultures prepared from three di¡erent
brain regions.
2. Materials and methods
2.1. Materials
Dulbecco’s modi¢ed Eagle’s medium (DMEM), £asks and other
material for cell culture, acrylamide, forskolin, lysophosphatidic acid
(LPA) and cycloheximide and antibodies against glial ¢brillary acidic
protein (GFAP) (polyclonal, G9269) and S100B (clone SHB1) were
purchased from Sigma. Fetal calf serum was purchased from Gibco;
horseradish peroxidase-conjugated secondary antibodies and nitrocel-
lulose membranes were from Amersham; peroxidase-conjugated poly-
clonal anti-S100 came from Dako. For GFAP immunocytochemistry
a polyclonal antibody (20334) from Dako was used.
2.2. Astrocyte cultures
Primary astrocyte cultures were prepared as previously described
[14]. Brie£y, hippocampus, cortex and cerebellum of newborn Wistar
rats (1^2 days old) were removed, placed in Ca2 and Mg 2-free
balanced salt solution (CMF-BSS; pH 7.4, containing 137 mM
NaCl; 5.36 mM KCl; 0.27 mM Na2HPO4 ; 1.1 mM KH2PO4 and
6.1 mM glucose), cleaned of meninges and mechanically dissociated
by sequential passage through a Pasteur pipet. The cell suspension
was centrifuged at 1000 rpm for 5 min. The supernatant was dis-
carded, the pellet resuspended in culture medium (pH 7.6) containing
1% DMEM; 8.39 mM HEPES; 23.8 mM NaHCO3 ; 0.1% fungizone;
0.032% garamicine and 10% fetal calf serum. The cells were plated at
a density of 1.5U105 cells/cm2 onto 24 well plates pre-treated with
poly-L-lysine. Cultures were maintained in 5% CO2/95% air at 37‡C
and allowed to grow to con£uence (20^24 DIV).
2.3. Gel electrophoresis and immunoblotting
Stopping solution (110 Wl, 2.1 mM EDTA, 50 mM Tris^HCl, 4%
SDS, pH 6.8) was added and the cells were scraped and transferred to
Eppendorf tubes. Samples were boiled for 2 min, cooled and 25 Wl of
a solution containing 40% glycerol, 5% mercaptoethanol, 50 mM
Tris^HCl, pH 6.8 and a trace of bromophenol blue was added. The
samples were applied to 10% gels. Following electrophoresis the pro-
teins were transferred to nitrocellulose and immunoblotting for GFAP
carried out as described previously [14]. Brie£y, the membranes were
blocked with 5% defatted milk in TBS medium (20 mM Tris, 500 mM
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NaCl, pH 7.5) for at least 2 h. Then the membranes were incubated
with 1:500 anti-GFAP in milk-TBS for 1 h and ¢nally with 1:3000
peroxidase-conjugated secondary antibody also for 1 h. Conjugates
were developed by the ECL method, using a kit from Amersham
and X-Omat ¢lm from Kodak.
2.4. Quanti¢cation and analysis of GFAP
This was done by scanning the ECL ¢lms in a Hewlett-Packard
ScanJet 6100C and determining optical densities with Optiquant (ver-
sion 02.00, Packard instrument) software. The results were expressed
as a percentage normalized to the value for the hippocampus.
2.5. Assay of S100B protein by ELISA
Assay of S100B was carried out by ELISA as described by Green et
al. [15]. To measure the liberation of S100B from the cultures (sub-
sequently referred to as ‘secretion’ since no parallel liberation of LDH
was observed) the DMEM medium was replaced with medium with-
out serum and samples were collected at di¡erent times during 24 h to
analyze the amount of S100B secreted. 50 Wl of sample plus 50 Wl of
barbital bu¡er (pH 8.6) were applied on microtiter plates previously
coated with monoclonal anti-S100B in carbonate bu¡er and blocked
with 1% bovine serum albumin. After washing, peroxidase-conjugated
anti-S100 diluted 1:1000 was added and incubation continued for 1 h.
The plate was washed and 0.2 ml of peroxidase substrate (Sigma Fast
OPD) was added and the plate incubated for a further 30 min in the
dark. The absorbance was measured at 492 nm on a microtiter plate
reader. The standard curve for S100B was linear between 0.1 and 4 ng/
ml. To measure the intracellular content of S100B the medium was
removed after 24 h and the cells were dissolved in lysis solution (PBS
containing 1 mM PMSF and 1 mM EGTA) and analyzed by ELISA.
After 24 h the cells were scraped and total protein was measured.
2.6. Immunocytochemistry
Con£uent cells were ¢xed with 4% paraformaldehyde in PBS for
30 min and then treated with 0.2% Triton X-100 in PBS for 10 min
and blocked with 5% BSA for 1 h. Cells were incubated overnight
with 1:200 diluted polyclonal anti-GFAP or monoclonal anti-S100B
at room temperature. Then the cells were incubated with second anti-
Fig. 1. Morphology of astrocytes in primary cultures prepared from di¡erent brain regions in the presence or absence of serum. Cell cultures
were prepared from neonatal rat brain as described in Section 2 and allowed to grow to con£uence (20^24 DIV) before viewing by phase-con-
trast optics (a^f) and ¢xing for immunocytochemistry for S100B (g^i) and GFAP (m^r). Scale bar: 50 Wm.
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body diluted 1:200 (peroxidase-conjugated anti-rabbit) for 2 h. Fi-
nally, cells were incubated for 10 min with 0.05% DAB/0.3% hydrogen
peroxide.
2.7. Image analysis
Cells were viewed in a Nikon Eclipse TE300 inverted microscope.
Before photographing images typical of a particular parameter at least
eight ¢elds were examined.
3. Results
3.1. Morphological di¡erences in astrocyte cultures
Astrocyte cultures prepared from hippocampus, cerebral
cortex and cerebellum and grown for 20^24 DIV in the pres-
ence of serum, showed clear morphological di¡erences in
phase-contrast microscopy (Fig. 1a^c). There were many pro-
cesses in astrocytes from cerebellum, few in astrocytes from
cortex and hardly any in astrocytes from hippocampus. In
absence of serum for 2 h these di¡erences were still clearer
because of a dramatic increase in processes in cerebellar as-
trocytes in contrast to almost unchanged astrocytes from hip-
pocampus and only partial stellation in cortical astrocytes
(Fig. 1d^f). Interestingly, process formation in cortical astro-
cytes induced by forskolin (and to a lesser extent by serum
deprivation) was di¡erent from the other structures: cell
bodies were elongated and processes were generally parallel
rather than stellate (Figs. 1e and 5Be). Immunocytochemistry
for GFAP and S100B, two marker proteins for astrocytes,
con¢rmed these observations, as well as showing the purity
of the cultures where more than 98% cells were GFAP- and
S100B-positive (Fig. 1g^r), thus excluding the possibility that
the morphological di¡erences may be due to contaminating
cells. Note the predominantly perinuclear location of the im-
munoreactivity to S100B, evident particularly in the hippo-
campus and previously reported in C6 glioma cells [16].
The cerebellum in situ contains a characteristic form of
radial glia known as the Bergmann glia, which are related
to astrocytes as they express GFAP. Whether Bergmann glia
were present in our cerebellar cultures is not known as a
characteristic marker for these cells is not available. However
the morphological homogeneity of the stellar cerebellar astro-
cytes in our cultures (Fig. 1f,i,r) suggested that if Bergmann
glia were growing under our conditions they were developing
into a radically di¡erent phenotype from the typical morphol-
ogy they exhibit in situ.
Fig. 2. Immunocontent of GFAP and S100B in astrocyte cultures
prepared from cerebellum (Cb), cerebral cortex (Cx) and hippocam-
pus (Hc). GFAP was measured by immunoblotting and densitomet-
ric scanning of the ECL ¢lms (see inset) and S100B by ELISA as
described in Section 2. Equal amounts of protein were analyzed.
Results are the mean ( þ S.E.M.) of 3^6 observations and are ex-
pressed as percentages of normalized values for hippocampus. Sig-
ni¢cantly di¡erent from hippocampus **P6 0.001; *P6 0.01 (AN-
OVA).
Fig. 3. Time-dependent release (A) and cell content (B) of S100B
from astrocyte cultures incubated in the absence of serum. (A) The
DMEM culture medium was replaced with medium without serum
and aliquots (50 Wl) were collected at di¡erent times to analyze the
amount of secreted S100B. (B) Intracellular content of S100B was
measured in control and serum-free incubated cells for 24 h. Points
are the mean ( þ S.E.M.) of 3^6 observations. Cb, cerebellum; Cx,
cerebral cortex; Hc, hippocampus.
Fig. 4. Inhibition of S100B secretion by cycloheximide. Secretion of
S100B was determined as indicated in Fig. 3 after incubation for
24 h in the presence or absence of serum and of cycloheximide
(0.5 Wg/ml). Results of four observations are expressed as percen-
tages of the normalized values for cells incubated with serum. *Sig-
ni¢cantly di¡erent from control (P6 0.01).
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3.2. Immunocontent and secretion of S100B in astrocytes from
di¡erent regions
In addition to the morphological di¡erences we found sig-
ni¢cant di¡erences in the immunocontent of GFAP and
S100B in astrocytes prepared from the three regions. The
S100B immunocontent of cerebellar astrocytes was nearly
2.5 fold higher than the level observed in hippocampal astro-
cytes, whereas the cerebellar GFAP immunocontent was ap-
proximately one half of the hippocampal content (Fig. 2).
Cortical contents of these proteins were not signi¢cantly dif-
ferent from hippocampal levels. Astrocytes from all three re-
gions secreted S100B when incubated in the absence of serum
for 24 h, but the secretion rate and the total amount secreted
from cerebellar astrocytes was strikingly higher than from
cortical or hippocampal astrocytes (Fig. 3A). Secretion was
accompanied by signi¢cant increases in the immunocontent of
S100B in the cells (Fig. 3B) and was dependent on protein
synthesis as it was inhibited by cycloheximide (Fig. 4). In all
three astrocyte cultures secretion was markedly greater in the
absence of serum.
In an attempt to discover whether the secretion of S100B
was associated with di¡erences in morphology we incubated
the astrocytes with forskolin and the lipid mitogen LPA. For-
skolin, through its ability to increase intracellular cyclic AMP,
is well known to induce stellation in astrocyte cultures [17]
and LPA, through its action in activating the small GTPase
RhoA, causes most stellar astrocytes to revert to the rounded
protoplasmic morphology [18,19]. Both compounds signi¢-
cantly increased S100B release in all three cultures when in-
cubated in the absence of serum through mechanisms which
were additive (Fig. 5A). However, as shown in Fig. 5B, secre-
tion was not associated with a process-bearing morphology:
thus, hippocampal astrocytes were protoplasmic after incuba-
tion with LPA and stellate after forskolin, but in both situa-
tions the secretion of S100B was approximately equal. More-
over, when forskolin-induced stellation in hippocampal and
Fig. 5. E¡ects of forskolin and LPA on the secretion of S100B (A) and on the morphology of cultured astrocytes from three regions (B). Cells
were incubated in serum-free medium in the presence of 10 WM forskolin or 2 WM LPA. A: Secretion. The concentration of S100B in the me-
dium was measured by ELISA after incubation for 2 h. Results are expressed as percentages of normalized values for control cells. Equal
amounts of protein were analyzed. Each bar represents the mean of 3^6 observations þ S.E.M. All experimental values are signi¢cantly di¡erent
from control (P6 0.01). B: Morphology. Phase-contrast images were photographed after incubation for 2 h. Scale bar: 50 Wm.
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cortical astrocytes was reversed by LPA, secretion of S100B
was further increased. By contrast LPA had no e¡ect on the
stellation induced in cerebellar astrocytes by serum-depriva-
tion or forskolin, an observation which merits further inves-
tigation (compare Fig. 1f with Fig. 5Bf,i).
4. Discussion
4.1. Morphological variation
We found that astrocyte cultures from three brain regions
were morphologically distinct and these di¡erences were in-
creased on withdrawal of serum for 2 h, con¢rming that the
phenotypic fate of astrocytes is determined in embryogenesis
and neonatal astrocytes are already programmed to develop a
characteristic morphology. Cell morphology depends on sig-
nal transduction pathways regulating the assembly of cyto-
skeletal proteins, particularly actin [20,21]. The integrity of
the actin cytoskeleton is regulated by the Rho family of small
GTPases [22,23] and in astrocytes stellation is associated with
down regulation of RhoA and depolymerization of F-actin
[19,22]. In hippocampal and cortical astrocytes, stellation is
reversed by LPA which up regulates the activity of RhoA
[19,23]. It was especially striking therefore to observe that in
cerebellar astrocytes stellation induced by serum deprivation
or forskolin was not reversed by LPA. This result suggests
that some aspects of the control of the actin cytoskeleton by
Rho family GTPases in cerebellar astrocytes are di¡erent
from the other structures.
4.2. Secretion of S100B in astrocyte cultures from three regions
The relatively high rate of secretion of S100B from cerebel-
lar astrocytes was associated with a higher immunocontent
compared with hippocampal or cortical astrocytes. The sig-
ni¢cance of this observation in relation to regional functional
variation is unknown. However S100B has extracellular roles
[12]. For example S100B stimulates the proliferation of astro-
cytes and C6 glioma cells [24] and the survival and extension
of neurites in neuronal cultures [25]. We have shown that
treatment of astrocyte cultures with S100B activates ERK
[26], a result which may be related to the e¡ect of the protein
on glial proliferation [24].
The increased secretion of S100B following treatment of
cells with forskolin (Fig. 5A) was expected since immunode-
tectable S100B is increased by agents that increase cyclic AMP
in astrocytes [27,28]. However, the increased secretion of
S100B given by LPA (Fig. 5A) was not observed. This e¡ect
of LPA was nearly additive with that of forskolin in all three
cultures, pointing to distinct mechanisms. However since the
mechanism of S100B secretion from cells is not understood it
is not possible to draw any conclusion about the site of action
of LPA.
4.3. S100B secretion and immunocontent in relation to
morphology
Cytoskeletal targets of S100B include inhibition of the
phosphorylation [29] and polymerization [30] of GFAP, mod-
ulation of microtubular function [16,31] and the actin-binding
protein capZ [32]. Further inhibition of S100B synthesis in cell
cultures results in micro¢lament reorganization and alteration
in cellular phenotype [33] and transgenic mice overexpressing
S100B show neural cytoskeletal changes [34]. These observa-
tions made it of interest to investigate whether S100B secre-
tion was associated with astrocyte morphology, particularly
process formation. However we found no evidence for such
an association. Presumably this negative result is related to
the complexity of the signal transduction pathways that reg-
ulate cell morphology.
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